2025-060-01 Laboratory Technician/Lab Manager
Under the leadership of Josep Tabernero, VHIO is an internationally recognized cancer center. Its multidisciplinary, collaborative model drives scientific progress and innovative cancer treatments.
The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Laboratory Technician/Lab Manager”
Application deadline: 15/12/2025
Number of vacancies: 1
Job description:
The Cancer Genome Engineering Lab is focused on dissecting the role of large-scale chromosomal changes in cancer. Our goal is to identify the mechanisms by which these genetic events allow tumor cells to evade immunity and resist to various therapies. For this we use novel genome engineering approaches and in vivo models of cancer.
Our team is looking for a highly motivated technician who would be a key player in moving forward our challenging and exciting research in a fun and inclusive environment. The main role will be to support ongoing projects with molecular biology, cell culture, immunostainings, and help the lab organization. This will entail implementing established SOPs and developing new protocols and producing high quality data to be included in research papers for publication.
Requirements:
- Formación Profesional (FP) in Laboratory, or a BSc, MSc and/or PhD degree in Molecular Biology, Biology, Biochemistry or similar field.
- Molecular Biology experiments (western blot, qPCR, DNA/RNA extraction, PCR)
- Fluent in English and Spanish (written & spoken).
- Autonomous person with teamwork skills and ability to work in various projects.
- Excellent organizational skills.
- Experience in cell biology techniques, e.g. flow cytometry, cell culture, immunohistochemistry, tissue processing.
- Animal course (not required but will be positively valued)
Additional information:
We offer:
- 📈The possibility of developing your professional career in a competitive environment.
- 🧠To be part of a center that is constantly developing, pursuing excellence in research and collaborating with leading teams.
- 🫱🏻🫲🏾We offer and promote a diverse and inclusive environment, and welcome all people equally, regardless of age, disability, gender, nationality, race, religion or sexual orientation.
- 🪴We care about our environment and understand the importance of sustainability. We have the GreenVhio program, which you can be a part of.
Conditions:
- 📝Permanent contract.
- 🗓️Full-time position, 37.5 hours per week.
- 💶Salary according to qualifications and experience following VHIO pay scales.
- 💳Flexible remuneration program (includes restaurant vouchers/cards, transport, medical insurance, and “baby daycare” voucher).
- ⏰Flexible working hours and measures to balance work, family, and personal life, and promote gender equality, as established in the VHIO collective agreement.
- 🗺️24 days of holidays and 6 personal days.
- 🎓Fully subsidized Catalan, Spanish, or English courses.
- 🏃➡️Take advantage of doing sports at great prices with Urban Sports Club.
- 🩺You’ll have access to weekly physiotherapy sessions at the office, offered at a reduced price for the team.
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.
- Department
- Division of Preclinical and Translational Research
About VHIO
The Vall d'Hebron Institute of Oncology (VHIO) is a leading center for personalized cancer medicine.
Thanks to its pioneering model of multidisciplinary and translational research, as well as its participation in consortia and projects with other prestigious centers worldwide, it has become one of the most important comprehensive centers in Europe. VHIO is able to rapidly translate the latest laboratory research discoveries into early-phase clinical trials, and thus, into new opportunities for patients.